Reticular
Interpretable AI for drug discovery
About
Reticular helps pharma companies discover drugs with AI models like AlphaFold by making them steerable, just like you can prompt LLMs. Today, limited validation data means companies spend millions on failed experiments trying to steer these models through trial and error. We’re piloting our AI interpretability technology with early-stage biotechs and scaling rapidly. Just a week after our pivot, we identified the first interpretable features ever found in protein models, allowing precise control over biological functions. Nithin and John met competing in Biology Olympiads before spending 4 years as roommates at MIT publishing ML/bio research in NeurIPS and Nature. We believe biological models encode far more information than anyone is currently using - our goal is to unlock this potential.
Founder
- John Yang
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Reticular.
See family office activity